Test Price
2,800 AED✅ Home Collection Available
NDUFA9 Gene Leigh Syndrome Genetic Test in UAE | 2,800 AED
Executive Summary & Core Metrics
The NDUFA9 Gene Leigh Syndrome Genetic Test delivers definitive molecular diagnosis using Next Generation Sequencing (NGS) with 99.9% diagnostic sensitivity. This ISO 9001:2015 accredited test (Cert: INT/EGQ/2509DA/3139) includes VIP mobile phlebotomy and temperature-controlled cold-chain home collection, available daily from 8 AM to 11 PM. Post-test telephonic clinical guidance is provided, with direct insurance billing verification via WhatsApp.
- ✅ 99.9% Diagnostic Sensitivity via ISO Accredited Processing (ISO 9001:2015 Cert: INT/EGQ/2509DA/3139)
- ✅ Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection
- ✅ Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation
- ✅ Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731
Test Overview & Methodology
This advanced genetic test analyzes the entire NDUFA9 gene using the Illumina NovaSeq NGS platform, providing comprehensive coverage for disease-causing mutations linked to Leigh syndrome (subacute necrotizing encephalomyelopathy). Unlike traditional Sanger sequencing which focuses on single exons, our NGS approach delivers full gene analysis with superior sensitivity and a significantly faster turnaround time.
| Feature | Our Test (Premium) | Closest Alternative |
|---|---|---|
| Precision | 99.9% NGS coverage, full gene analysis | Sanger sequencing (single exon focus) |
| Methodology | Illumina NovaSeq NGS Platform | PCR + Sanger (limited sensitivity) |
| Turnaround Time | 3–4 Weeks | 6–8 Weeks |
| Sample Types | Whole Blood, Extracted DNA, FTA Card | Whole blood only |
Physician Insight & Safety Protocols
“As a Consultant Medical Genetics specialist, I emphasize that this NDUFA9 gene test provides crucial molecular confirmation for Leigh syndrome. A positive result confirms a genetic susceptibility, yet clinical correlation with neuroimaging and metabolic workup is essential for a precise diagnosis. This test should be interpreted within the full clinical picture by a qualified genetics professional.”
— Ms. Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory Notice
⚠️ Medication Advisory: Do not discontinue prescribed medication without consulting your doctor. This test is for diagnostic purposes only and does not replace ongoing clinical management or treatment decisions made by your healthcare provider.
Safety Exclusion Criteria & ER Red Flags
- Active severe infection or acute metabolic crisis – postpone elective testing.
- If the patient exhibits sudden-onset neurological deterioration (e.g., seizures, loss of consciousness, stroke-like episodes), seek emergency care immediately; this test is not intended for acute diagnosis.
- Home collection is contraindicated in patients with severe coagulopathy or severe dermatological conditions at venipuncture sites; contact our clinical team for alternative arrangements.
Patient FAQ & Clinical Guidance
1. What is the NDUFA9 gene test for Leigh syndrome?
This test uses Next Generation Sequencing (NGS) to analyze the entire NDUFA9 gene for disease-causing mutations linked to Leigh syndrome, a severe neurological condition. The analysis includes full exonic coverage and detects single nucleotide variants, insertions, deletions, and splice-site alterations.
2. How is the sample collected for this genetic test?
A certified phlebotomist collects a small blood sample from your arm using a painless venipuncture, or you can provide an extracted DNA sample or FTA card. Our VIP mobile phlebotomy service is available daily from 8 AM to 11 PM with temperature-controlled cold-chain transport to the laboratory.
3. What does a positive result mean for my child?
A positive result indicates the presence of a known pathogenic variant in NDUFA9, confirming genetic susceptibility to Leigh syndrome. This finding guides clinical surveillance, metabolic management, and informed family planning. All results are reviewed during a telephonic post-test genetic counseling session.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance: This test is performed under the regulatory oversight of the Dubai Health Authority (DHA) and adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) for all patient data handling. Health information processing complies with Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent protocols follow Federal Decree-Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | NDUFA9 Gene Leigh Syndrome Genetic Test (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type / Matrix | Whole Blood, Extracted DNA, FTA Card |
| Methodology Used | Next Generation Sequencing (NGS) on Illumina NovaSeq Platform |
| ICD-10-CM Code | G31.82 |
| LOINC Code | 91854-7 |
| DHA Facility License & Laboratory Address | DHA License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians